Cognitive Rehabilitation for Depression
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study staff or your healthcare provider.
What data supports the effectiveness of the treatment Goal-focused Supportive Contact, Motivationally Enhanced Compensatory Cognitive Training for Major Depressive Disorder (ME-CCT-MDD)?
Research shows that cognitive training can significantly improve cognitive and emotional outcomes in people with major depressive disorder, suggesting it could be a valuable treatment option. Additionally, online working memory training has shown lasting improvements in self-reported cognitive functioning, indicating potential benefits for similar cognitive rehabilitation approaches.12345
Is cognitive rehabilitation for depression safe for humans?
How is the treatment ME-CCT-MDD different from other treatments for depression?
ME-CCT-MDD is unique because it combines motivational support with cognitive training to specifically target cognitive impairments in depression, which are often not addressed by standard treatments. This approach aims to improve both cognitive and emotional symptoms, offering a novel way to enhance overall functioning in individuals with major depressive disorder.136810
What is the purpose of this trial?
Individuals with depression often describe difficulties with memory, attention, concentration, and overall cognitive functioning, which can persist even after mood episodes get better, and can affect treatment and health outcomes.The primary objective of this pilot clinical trial is to evaluate the feasibility and acceptability of a manualized, 8-week, Compensatory Cognitive Training (CCT) intervention for Veterans who received treatment for MDD in the past year and have persistent cognitive functioning deficits. The investigators will compare Motivationally Enhanced Compensatory Cognitive Training for Major Depressive Disorder (ME-CCT-MDD) to a robust comparator, Goal-focused Supportive Contact (GSC), to evaluate differences in outcome measures.The investigators hypothesize that Motivationally Enhanced Compensatory Cognitive Training for Major Depressive Disorder (ME-CCT-MDD) will be feasible and acceptable to participants in a pilot trial of ME-CCT-MDD vs. Goal-focused supportive contact (GSC) for Veterans with recent MDD treatment and persistent cognitive symptoms.This study will also evaluate the preliminary magnitude and direction of symptom change on measures of objective cognitive functioning, psychiatric symptomatology, psychosocial functioning, and quality of life.The investigators hypothesize that CCT will improve objective cognitive functioning, psychiatric outcomes, psychosocial functioning, and quality of life in Veterans with recent MDD-related cognitive functioning deficits.Participants who agree to participate in the study will:1. Take part in an assessment of their cognition, symptoms, and functioning, which will take approximately 2 hours. The assessment will include an interview about their medical, psychiatric, and cognitive history. It will also include questionnaires about their symptoms and daily functioning as well as neuropsychological tests, which are paper-pencil tests that evaluate aspects of cognition such as memory, attention, and problem-solving skills.2. Be randomly assigned (like the flip of a coin) to receive Goal-Focused Supportive Contact or Compensatory Cognitive Training. Both treatments will involve weekly groups with a mental health provider for approximately 2 hours per week for 8 weeks. Goal-Focused Treatment includes setting and achieving short-term and long-term goals for improving cognition and functioning. Compensatory Cognitive Training includes training in strategies to improve cognition and manage stress.3. Complete a follow-up assessment of cognition, symptoms, and functioning 8 weeks after they begin treatment, as well as a brief interview about their experience in the group. These assessment sessions will take approximately 2 hours.
Research Team
Maya O'Neil, PhD
Principal Investigator
Portland VA Medical Center
Joren Adams
Principal Investigator
Portland VA Medical Center
Eligibility Criteria
This trial is for Veterans who have been treated for Major Depressive Disorder (MDD) within the past year and are still struggling with cognitive issues like memory and concentration. Participants must be willing to undergo assessments, attend weekly group sessions for 8 weeks, and complete follow-up evaluations.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo an assessment of cognition, symptoms, and functioning, including interviews and neuropsychological tests
Treatment
Participants receive either ME-CCT-MDD or GSC intervention, involving weekly group sessions for cognitive training or supportive contact
Follow-up
Participants complete a follow-up assessment of cognition, symptoms, and functioning, including a brief interview about their experience
Treatment Details
Interventions
- Goal-focused Supportive Contact
- Motivationally Enhanced Compensatory Cognitive Training for Major Depressive Disorder (ME-CCT-MDD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Portland VA Medical Center
Lead Sponsor
Oregon Health and Science University
Collaborator